WO1995016658A1 - Process for preparing intermediates for the synthesis of antifungal agents - Google Patents

Process for preparing intermediates for the synthesis of antifungal agents Download PDF

Info

Publication number
WO1995016658A1
WO1995016658A1 PCT/US1994/013778 US9413778W WO9516658A1 WO 1995016658 A1 WO1995016658 A1 WO 1995016658A1 US 9413778 W US9413778 W US 9413778W WO 9516658 A1 WO9516658 A1 WO 9516658A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
mixture
acid
ch2ci2
olefin
Prior art date
Application number
PCT/US1994/013778
Other languages
French (fr)
Inventor
Shen-Chun Kuo
Donald Hou
Zheng-Yun Zhan
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Priority to EP95905849A priority Critical patent/EP0734369B1/en
Priority to AU14304/95A priority patent/AU1430495A/en
Priority to DE69414724T priority patent/DE69414724T2/en
Priority to JP7516792A priority patent/JPH09507215A/en
Publication of WO1995016658A1 publication Critical patent/WO1995016658A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/24—Halogenated aromatic hydrocarbons with unsaturated side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/64—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by simultaneous introduction of -OH groups and halogens

Definitions

  • PCT International Publication No. WO 89/04829 U.S. Patent No. 5,039,676, and PCT International Publication No. WO 93/09114 disclose substituted tetrahydrofuran azole compounds having utility as antifungal agents. A number of processes for the synthesis of these compounds are known.
  • Dialkylmalonate derivatives of the formula IV are examples of the formula IV
  • I V compounds of the formula V are typically low yielding, inefficient and not amenable to commercial scale synthesis. It is therefore desirable to develop a chemically efficient, high yield process for the synthesis of compounds of the formula V.
  • the present invention comprises a process for preparing allylic halide compounds of the formula I
  • Preferred acids for dehydration of the tertiary alcohol include p-TsOH and H2SO4.
  • the olefin is treated with a halogenating agent selected from NCS or NBS. More preferably the halogenating agent is used in the presence of a catalyst to form a compound of the formula I wherein X is Br or Cl.
  • Preferred catalysts include AIBN and organic peroxides, such as benzoyl peroxide.
  • the halogenating agent is selected from NCS, NBS or I2, and is used in the presence of water to form a halohydrin of the formula VI
  • the present invention further comprises a process as described above wherein the tertiary alcohol of formula II is prepared by reacting 2',4'-difluoroacetophenone with an methylating agent.
  • the methylating agent is an organometallic agent such as methyl grignard, e.g. CHsMgBr, or methyllithium.
  • halogenating agent means a reagent capable of reacting with an allylic hydrocarbon moiety to form an allylic halide (e.g. bromide, chloride or iodide) or, in the presence of water, a halohydrin.
  • Preferred halogenating agents include 1 ,3-dichloro-5,5-dimethylhydantoin, 1 ,3- dibromo-5,5-dimethylhydantoin, NCS, NBS and I2;
  • “acid” means an organic or inorganic acid capable of catalyzing the dehydration of a tertiary alcohol to form an olefin, or a halohydrin to form an allylic halide, with preferred acids including p- TsOH and H 2 S0 4 ;
  • “catalyst” means a substance capable of initiating reactions involving organic free radicals, such as AIBN and organic peroxides, e.g. benzoyl peroxide;
  • Lewis acid means a reagent capable of catalyzing a Friedel-Crafts reaction, such as AICI3, SnCU or ZnCt ⁇ ;
  • methylating agent means an organometallic reagent capable of delivering a nucleophilic methyl group to the carbonyl carbon of a ketone to form a tertiary alcohol.
  • Preferred methylating agents include methyl grignard and methyllithium.
  • ethyl acetate EtOAc
  • diethyl ether Et 2 0
  • ethanol EtOH
  • tetrahydrofuran THF
  • dimethylsulfoxide DMSO
  • methanol MeOH
  • NCS N-chlorosuccinimide
  • N-bromosuccinimide N-bromosuccinimide
  • p-TsOH p-toluenesulfonic acid
  • AIBN azobisisobutyronitrile
  • the present invention comprises a process as shown in Reaction Scheme A for preparing compounds of the formula I.
  • Step A1 2',4'-difluoroacetophenone is reacted with a methylating agent, preferably methyl grignard or methyllithium, in a suitable solvent, such as THF, CH2CI2 or toluene, at 20° to -100°C, preferably at 0° to -80°C, to form a tertiary alcohol of the formula II.
  • a methylating agent preferably methyl grignard or methyllithium
  • a suitable solvent such as THF, CH2CI2 or toluene
  • the tertiary alcohol II is prepared by reacting p-difluorobenzene and acetone in a suitable solvent, such as CS2 or CH2CI2, in the presence of a suitable Lewis Acid, such as AICI3, SnCU or ZnCl2-
  • a suitable Lewis Acid such as AICI3, SnCU or ZnCl2-
  • the tertiary alcohol II is prepared by treating 2,4-difluorobromobenzene with Mg in a suitable solvent, such as Et2 ⁇ , THF or toluene, to form the Grignard reagent and reacting the Grignard reagent with acetone to form the alcohol II.
  • the tertiary alcohol II is dehydrated by heating at 30° to 100°C, preferably at 50° to 90°C, in a suitable solvent, such as CH2CI2 or toluene, in the presence of an acid, preferably pTsOH or H2SO4, to form the olefin III.
  • a suitable solvent such as CH2CI2 or toluene
  • an acid preferably pTsOH or H2SO4
  • Step A3(a) the olefin III is treated with a halogenating agent, such as NCS, 1 ,3-dichloro-5,5-dimethylhydantoin, NBS or 1 ,3- dibromo-5,5-dimethylhydantoin, in a suitable solvent, such as CCI4, preferably in the presence of a catalyst, such as AIBN or an organic peroxide, such as benzoyl peroxide, at 50° to 150°C, preferably at 80° to 130°C, to form a compound of the formula I, wherein X is Cl or Br.
  • a halogenating agent such as NCS, 1 ,3-dichloro-5,5-dimethylhydantoin, NBS or 1 ,3- dibromo-5,5-dimethylhydantoin
  • a suitable solvent such as CCI4
  • a catalyst such as AIBN or an organic peroxide, such as benzoyl peroxide
  • Step A3(b) the olefin III is treated with a halogenating agent, such as NCS, NBS or I2, in a suitable solvent, such as DMSO or CH3CN, in the presence of water, at 0° to 120°C, preferably at 20° to 100°C, to form a halohydrin of the formula IV.
  • a suitable solvent such as DMSO or CH3CN
  • the halohydrin is then dehydrated by heating at 30° to 100°C, preferably at 40° to 70°C, in a suitable solvent, such as CH2CI2, in the presence of an acid, preferably p-TsOH, to form a compound of the formula I, wherein X is Br, Cl or I.
  • the starting compound 2',4'-difluoroacetophenone is known, and is commercially available or can be prepared by established methods. The following preparations and examples are illustrative of the process of the present invention.
  • the analogous chlorohydrin can be prepared via substantially the same procedure, by substituting NCS for NBS.
  • the chlorohydrin product of Preparation 4 is converted to a 1 :1 mixture of the allylic chloride and the isomeric vinyl chloride.
  • the product is an impure mixture comprising approximately 46% of the desired allylic chloride, and 31 % of the vinyl chloride isomer.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Disclosed is a process for preparing allylic halides of the formula (I), wherein X is Cl, Br or I, for use as intermediates in the synthesis of substituted tetrahydrofuran azole anti-fungal agents.

Description

PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS
BACKGROUND OF THE INVENTION
PCT International Publication No. WO 89/04829, U.S. Patent No. 5,039,676, and PCT International Publication No. WO 93/09114 disclose substituted tetrahydrofuran azole compounds having utility as antifungal agents. A number of processes for the synthesis of these compounds are known. In addition, PCT International Application No. PCT/US94/04355, claiming priority as a CIP of U.S. Serial No. 08/055,268, describes a process for preparing chiral intermediates for use in the preparation of these antifungal agents. Dialkylmalonate derivatives of the formula IV
Figure imgf000003_0001
wherein R is C-i-Cβ alkyl, are important intermediates used in this process. An efficient synthesis of compounds of the formula IV is therefore a key factor in the synthesis of antifungal compounds via this process. Preparation of compounds of the formula IV is most readily accomplished by the process described in US Serial No. 08/055,268. This process, as shown in Reaction 1 , comprises reacting a dialkyl malonate anion, wherein M+ is a suitable metal counterion and R is C-|-C6 alkyl, with a compound of the formula V, wherein Z is a leaving group selected from Br, -OS02CH3 or -OSθ2C6H CH3) to form a compound of formula IV. However, the prior art methods for preparing
Reaction 1 :
I V
Figure imgf000003_0002
compounds of the formula V are typically low yielding, inefficient and not amenable to commercial scale synthesis. It is therefore desirable to develop a chemically efficient, high yield process for the synthesis of compounds of the formula V.
SUMMARY OF THE INVENTION
The present invention comprises a process for preparing allylic halide compounds of the formula I
Figure imgf000004_0001
wherein X is Cl, Br or I, comprising dehydrating a tertiary alcohol of the formula II
Figure imgf000004_0002
by heating in the presence of an acid to form an olefin of the formula III
Figure imgf000004_0003
and treating the olefin III with a halogenating agent to form the allylic halide compound of formula I.
Preferred acids for dehydration of the tertiary alcohol include p-TsOH and H2SO4. Preferably the olefin is treated with a halogenating agent selected from NCS or NBS. More preferably the halogenating agent is used in the presence of a catalyst to form a compound of the formula I wherein X is Br or Cl. Preferred catalysts include AIBN and organic peroxides, such as benzoyl peroxide.
In an alternative embodiment, the halogenating agent is selected from NCS, NBS or I2, and is used in the presence of water to form a halohydrin of the formula VI
Figure imgf000005_0001
wherein X is Br, Cl or I, followed by dehydrating the halohydrin by heating in the presence of an acid to form a compound of the formula I wherein X is Br, Cl or I.
The present invention further comprises a process as described above wherein the tertiary alcohol of formula II is prepared by reacting 2',4'-difluoroacetophenone with an methylating agent. The methylating agent is an organometallic agent such as methyl grignard, e.g. CHsMgBr, or methyllithium.
DETAILED DESCRIPTION
As used herein, the term
"halogenating agent" means a reagent capable of reacting with an allylic hydrocarbon moiety to form an allylic halide (e.g. bromide, chloride or iodide) or, in the presence of water, a halohydrin. Preferred halogenating agents include 1 ,3-dichloro-5,5-dimethylhydantoin, 1 ,3- dibromo-5,5-dimethylhydantoin, NCS, NBS and I2;
"acid" means an organic or inorganic acid capable of catalyzing the dehydration of a tertiary alcohol to form an olefin, or a halohydrin to form an allylic halide, with preferred acids including p- TsOH and H2S04; "catalyst" means a substance capable of initiating reactions involving organic free radicals, such as AIBN and organic peroxides, e.g. benzoyl peroxide;
"Lewis acid" means a reagent capable of catalyzing a Friedel-Crafts reaction, such as AICI3, SnCU or ZnCtø;
"methylating agent" means an organometallic reagent capable of delivering a nucleophilic methyl group to the carbonyl carbon of a ketone to form a tertiary alcohol. Preferred methylating agents include methyl grignard and methyllithium.
The following solvents and reagents employed in the process of the present invention are identified by the abbreviations indicated: ethyl acetate (EtOAc); diethyl ether (Et20); ethanol (EtOH); tetrahydrofuran (THF); dimethylsulfoxide (DMSO); methanol (MeOH); N-chlorosuccinimide (NCS); N-bromosuccinimide (NBS); p-toluenesulfonic acid (p-TsOH); azobisisobutyronitrile (AIBN).
The present invention comprises a process as shown in Reaction Scheme A for preparing compounds of the formula I.
Reaction Scheme A
Step A1
Figure imgf000006_0001
Step A2
Figure imgf000006_0002
I I I Step A3(a)
Figure imgf000007_0001
or
Step A3(b)
Figure imgf000007_0002
In Step A1 , 2',4'-difluoroacetophenone is reacted with a methylating agent, preferably methyl grignard or methyllithium, in a suitable solvent, such as THF, CH2CI2 or toluene, at 20° to -100°C, preferably at 0° to -80°C, to form a tertiary alcohol of the formula II.
Alternatively, the tertiary alcohol II is prepared by reacting p-difluorobenzene and acetone in a suitable solvent, such as CS2 or CH2CI2, in the presence of a suitable Lewis Acid, such as AICI3, SnCU or ZnCl2- In yet another alternative, the tertiary alcohol II is prepared by treating 2,4-difluorobromobenzene with Mg in a suitable solvent, such as Et2θ, THF or toluene, to form the Grignard reagent and reacting the Grignard reagent with acetone to form the alcohol II.
In Step A2, the tertiary alcohol II is dehydrated by heating at 30° to 100°C, preferably at 50° to 90°C, in a suitable solvent, such as CH2CI2 or toluene, in the presence of an acid, preferably pTsOH or H2SO4, to form the olefin III.
In Step A3(a), the olefin III is treated with a halogenating agent, such as NCS, 1 ,3-dichloro-5,5-dimethylhydantoin, NBS or 1 ,3- dibromo-5,5-dimethylhydantoin, in a suitable solvent, such as CCI4, preferably in the presence of a catalyst, such as AIBN or an organic peroxide, such as benzoyl peroxide, at 50° to 150°C, preferably at 80° to 130°C, to form a compound of the formula I, wherein X is Cl or Br.
Alternatively, in Step A3(b), the olefin III is treated with a halogenating agent, such as NCS, NBS or I2, in a suitable solvent, such as DMSO or CH3CN, in the presence of water, at 0° to 120°C, preferably at 20° to 100°C, to form a halohydrin of the formula IV. The halohydrin is then dehydrated by heating at 30° to 100°C, preferably at 40° to 70°C, in a suitable solvent, such as CH2CI2, in the presence of an acid, preferably p-TsOH, to form a compound of the formula I, wherein X is Br, Cl or I.
The starting compound 2',4'-difluoroacetophenone is known, and is commercially available or can be prepared by established methods. The following preparations and examples are illustrative of the process of the present invention.
PREPARATION 1
Figure imgf000008_0001
Combine 8.11 g (52 mmol) of 2',4'-difluoroacetophenone and 45 mL of toluene and cool the mixture to -78°C. Slowly add 20 mL of a 3M solution of CHsMgBr and stir the reaction mixture overnight. Quench the mixture with 50 mL of water and 20 mL of 1 N HCI
(aqueous), then extract with 50 mL of EtOAc. Concentrate the extract in vacuo to give 9.06 g of the tertiary alcohol product. 1 H NMR (CDCI3): 7.60-7.54 (m, 1 H); 6.89-6.78 (m, 2H); 2.10 (br s, 1 H); 1.65 (s, 6H).
PREPARATION 2
Figure imgf000009_0001
Combine 9.06 g of the product of Preparation 1 and 45 mL of toluene, add 0.65 g of H2SO4, and heat the mixture to 80°-85°C for 3 h. Quench the reaction mixture with 20 mL of 1 N NaOH (aqueous) and extract with 50 mL of EtOAc. Concentrate the extract in vacuo to a residue. Distill the residue under vacuum to give 5.68 g of the olefin product. 1H NMR (CDCI3): 7.35-7.25 (m, 1 H); 6.89-6.79 (m, 2H); 5.24 (d, 2H); 2.15 (s, 3H).
PREPARATION 3
Figure imgf000009_0002
Slowly add a solution of 50 g of 2',4'-difluoro- acetophenone in 100 mL of CH2CI2 to a chilled (0°C) mixture of 120 mL of 3M CH3MgBr and 500 mL of CH2CI2. Stir the resulting mixture at 0°C for 30 min., then quench the reaction by slowly adding (dropwise) 50 mL of water. Stir the mixture for 20 min, then add 400 mL of 1 N HCI (aqueous) and stir at room temperature for 30 min. Separate the organic and aqueous phases of the mixture and wash the organic layer with 300 mL of water, then with 300 mL of brine. Combine the aqueous solutions and extract with CH2CI2 (2 X 150 mL). Combine the two organic extracts and wash with brine. Combine the extracts and the original organic solution, dry over MgSθ4, then filter and collect the filtrate. Add 5 g of p-TsOH to the filtrate and distill the mixture (bath temperature at 70°C) to remove 600 mL of CH2CI2. Add 500 mL of CH2CI2 and repeat the distillation. Repeat the addition distillation process with four more 500 mL portions of CH2CI2, to give a final solution volume of @ 400 mL. Add 500 mL of saturated NaHCθ3 (aqueous) to the solution and stir for 2 h at room temperature. Separate the layers and concentrate the organic solution in vacuo (20 mm Hg) to a residue. Distill the residue at high vacuum (1.8 mm Hg) and collect the fraction boiling at 56°-58°C to give 45 g of the olefin product.
PREPARATION 4
Figure imgf000010_0001
Combine 5 mL of a 3M solution of CHsMgBr in Et2θ and 30 mL of CH2CI2 and cool the mixture to 0°C. Add a solution of 3.0 g of α-chloro-2',4'-difluoroaectophenone in 10 mL of CH2CI2 and stir at 0°C for 10 min. Slowly add 1 mL of water, then 15 mL of 1 N HCI (aqueous). Separate the layers and extract the aqueous layer with CH2CI2 (2 X 10 mL). Combine the extracts and the original organic layer and wash with brine. Dry the solution over MgS04, then concentrate in vacuo to give 3.2 g of the chlorohydrin product. 1H NMR (CDCI3): 7.72-7.66 (m, 1 H); 7.00-6.81 (m, 2H); 4.00 (d of d, 2H); 2.81 (br s, 1 H); 1.69 (s, 3H). EXAMPLE 1
Step A
Figure imgf000011_0001
Combine 5.3 g of the olefin, 50 mL of DMSO and 1.5 mL of water. Carefully add 7.4 g of NBS in 5 portions and stir the resulting mixture at room temperature for 1 h. Dilute the mixture with 200 mL of water, then extract with hexane (3 X 120 mL). Combine the extracts, wash the combined extracts with water, then with brine, and dry over MgSθ4. Concentrate in vacuo to give 8.3 g of the bromohydrin product. 1H NMR (CDCI3): 7.77-7.68 (m, 1 H); 7.03-6.96 (m, 2H); 3.98 (d of d, 2H); 2.79 (br s, 1 H); 1.78 (s, 3H).
The analogous chlorohydrin can be prepared via substantially the same procedure, by substituting NCS for NBS.
Step B
Figure imgf000011_0002
Combine 0.6 g of the bromohydrin product of Step A, 30 mg of p-TsOH and 30 mL of CH2CI2. Distill the mixture (60° bath) to remove the bulk of the solvent, then add 30 mL of CH2CI2 and distill again. Repeat the solvent addition/distillation process with 4 additional 30 mL aliquots of CH2CI2, distilling to a residue. Dilute the residue with 30 mL of CH2CI2, wash with saturated NaHCθ3 (aqueous), then with brine, and dry over MgS04. Concentrate in vacuo to a residue to give 0.56 g of the product. The product is a mixture of the desired allylic bromide (81.1 %) and its vinyl bromide isomer, e.g. a compound of the formula
Figure imgf000012_0001
(18.9%) as determined by 1H NMR integration. The allylic bromide product is characterized by 1H NMR (CDCI3): 7.46-7.30 (m, 2H); 6.97- 6.84 (m, 1 H); 5.51 (d, 1 H); 4.47 (d, 1 H); 4.39 (s, 2H).
Following substantially the same procedure, the iodohydrin product of Example 2 is converted to the allylic iodide of formula
Figure imgf000012_0002
(96.4%), along with 3.6% of the isomeric vinyl iodide.
Similarly, using n-heptane as the solvent, the chlorohydrin product of Preparation 4 is converted to a 1 :1 mixture of the allylic chloride and the isomeric vinyl chloride.
EXAMPLE 2
Figure imgf000012_0003
Combine 7.62 g of I2, 3.51 g of KIO3, 120 mL of water and 120 mL of CH3CN, then add 1.5 mL of H2SO4 and a solution of 9.3 g of the olefin in 40 mL of 1 :1 CHsCN/water. Heat the resulting mixture to 100°C for 30 min., then cool to room temperature. Dilute the mixture with water to a volume of 500 mL then treat the mixture with Na2S2θ3. Extract with EtOAc (3 X 150 mL), wash the combined extracts successively with Na2S2θ3 (aqueous), water, and brine. Dry the extracts over MgS04 and concentrate in vacuo to give 17.8 g of the iodohydrin product. 1H NMR (CDCI3): 7.64-7.56 (m, 1 H); 6.93-6.77 (m, 2H); 3.80 (d of d, 2H); 2.47 (br s, 1 H); 1.72 (s, 3H).
EXAMPLE 3
Figure imgf000013_0001
Combine 1.5 g of the olefin, 35 mL of CCI4, 3.0 g of NBS and 0.07 g of benzoyl peroxide. Heat the mixture to 95°-100°C for 3 days. Quench with 10 mL of 1 N NaOH (aqueous) and 30 mL of water, then extract with CH2CI2 (2 X 100 mL). Concentrate in vacuo to a residue. Chromatograph the residue (silica gel, 10% EtOAc/hexane) to give 1.37 g of the allylic bromide product.
EXAMPLE 4
Figure imgf000013_0002
Combine 1.54 g of the olefin, 40 mL of chlorobenzene, 1.5 g of NCS and 50 mg of AIBN. Heat the mixture to 130°C for 18 h. Cool the mixture to 0°C, filter to remove the solids and concentrate the filtrate in vacuo to give 1.86 g of the product. The product is an impure mixture comprising approximately 46% of the desired allylic chloride, and 31 % of the vinyl chloride isomer.
EXAMPLE 5
Figure imgf000014_0001
Combine 6.25 g of KOCH3, 200 mL of EtOH and 13.6 mL of diethyl malonate and stir the mixture for 5 min. Add 40 mL of DMSO, stir for 10 min., then add a solution of 12.5 g of the allylic iodide of Example 2 in 40 mL of EtOH. Stir the mixture for 30 min, quench with 40 mL of water and 100 mL of 1 N HCI (aqueous). Extract with n-heptane (3 X 250 mL), combine the extracts and wash the extracts with water, then with brine. Dry the extracts over MgS04, then concentrate in vacuo to give 13.3 g of the malonate product. H NMR (CDCI3): 7.30-7.19 (m, 1 H); 6.89- 6.78 (m, 2H); 5.25 (d, 2H); 4.17 (q, 4H); 3.41 (t, 1 H); 3.08 (d, 2H); 1.12 (t, 6H).

Claims

We Claim:
1. A process for preparing allylic halide compounds of the formula
Figure imgf000015_0001
wherein X is Cl, Br or I, comprising dehydrating a tertiary alcohol of the formula
Figure imgf000015_0002
by heating in the presence of an acid to form an olefin of the formula
Figure imgf000015_0003
and treating the olefin with a halogenating agent to form the allylic halide.
2. The process of claim 1 wherein the acid for dehydration of the tertiary alcohol is p-toluenesulfonic acid or H2SO4.
3. The process of claims 1 or 2 wherein the halogenating agent is selected from N-chlorosuccinimide, 1 ,3-dichloro-5,5- dimethylhydantoin, N-bromosuccinimide or 1 ,3-dibromo-5,5- dimethylhydantoin.
4. The process of claims 1 , 2 or 3 wherein the halogenating agent is used in the presence of a catalyst.
5. The process of claim 4 wherein the catalyst is azobisisobutyronitrile or an organic peroxide.
6. The process of claim 5 wherein the organic peroxide is benzoyl peroxide.
7. The process of claims 1 or 2 wherein the halogenating agent is used in the presence of water, to form a halohydrin of the formula
Figure imgf000016_0001
wherein X is Br, Cl or I, and the halohydrin is dehydrated by heating in the presence of an acid to form the allylic halide.
8. The process of claim 7 wherein the halogenating agent is selected from N-chlorosuccinimide, N-bromosuccinimide or I2.
9. The process of claim 8 wherein the acid for dehydrating the halohydrin is p-toluenesulfonic acid.
10. The process of claim 1 wherein the tertiary alcohol is prepared by reacting 2',4'-difluoroacetophenone with a methylating agent.
11. The process of claim 10 wherein the methylating agent is CH3MgBr, or methyllithium.
PCT/US1994/013778 1993-12-13 1994-12-09 Process for preparing intermediates for the synthesis of antifungal agents WO1995016658A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP95905849A EP0734369B1 (en) 1993-12-13 1994-12-09 Process for preparing intermediates for the synthesis of antifungal agents
AU14304/95A AU1430495A (en) 1993-12-13 1994-12-09 Process for preparing intermediates for the synthesis of antifungal agents
DE69414724T DE69414724T2 (en) 1993-12-13 1994-12-09 METHOD FOR PRODUCING INTERMEDIATE PRODUCTS FOR SYNTHESIS OF ANTIFUNGAL AGENTS
JP7516792A JPH09507215A (en) 1993-12-13 1994-12-09 Method for preparing intermediates in antifungal drug synthesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/166,332 1993-12-13
US08/166,332 US5349099A (en) 1993-12-13 1993-12-13 Process for preparing intermediates for the synthesis of antifungal agents

Publications (1)

Publication Number Publication Date
WO1995016658A1 true WO1995016658A1 (en) 1995-06-22

Family

ID=22602818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/013778 WO1995016658A1 (en) 1993-12-13 1994-12-09 Process for preparing intermediates for the synthesis of antifungal agents

Country Status (10)

Country Link
US (1) US5349099A (en)
EP (1) EP0734369B1 (en)
JP (1) JPH09507215A (en)
AT (1) ATE173456T1 (en)
AU (1) AU1430495A (en)
CA (1) CA2178807A1 (en)
DE (1) DE69414724T2 (en)
ES (1) ES2123949T3 (en)
SG (1) SG45428A1 (en)
WO (1) WO1995016658A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835860B2 (en) 2002-02-01 2004-12-28 Merck & Co., Inc. Iodohydroxylation of olefins
WO2011144656A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Preparation of posaconazole intermediates
US9040539B2 (en) 2010-05-19 2015-05-26 Sandoz Ag Process for the preparation of chiral triazolones
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
CN105777539A (en) * 2016-03-30 2016-07-20 浙江大学宁波理工学院 Synthesis method of 2-[2-(2,4-diflurophenyl)propenyl]-1,3-diethyl malonate
CN105777486A (en) * 2016-03-30 2016-07-20 浙江大学宁波理工学院 Synthesis method of 2-[2-(2,4-diflurophenyl)-2-propen-1-yl)-1,3-propanediol
US9493428B2 (en) 2011-06-16 2016-11-15 Sandoz Ag Process for the preparation of a chiral compound

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442093A (en) * 1994-05-09 1995-08-15 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
CN105622413B (en) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 The synthetic method of 2 [2 (2,4 difluorophenyl) pi-allyl] 1,3 diethyl malonates
CN105622412B (en) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 The method of one kind 2 [2 (2,4 difluorophenyl) pi-allyl] 1,3 diethyl malonates of synthesis
CN105732311B (en) * 2016-03-30 2017-12-22 宁波新凯生物科技有限公司 The method of one kind 2 [base of 2 (2,4 difluorophenyl) 2 propylene 1] 1,3 propane diols of synthesis
CN114671737B (en) * 2022-04-18 2023-10-24 张家口市格瑞高新技术有限公司 Preparation method of posaconazole main ring intermediate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087473A (en) * 1976-11-03 1978-05-02 The Dow Chemical Company Preferential aliphatic halogenation of ar-substituted alkylbenzenes
JPH0717634B2 (en) * 1987-11-20 1995-03-01 シェリング・コーポレーション Tri- and tetra-substituted-oxetanes and tetrahydrofuran and its intermediates
HUT53889A (en) * 1988-03-04 1990-12-28 Sankyo Co. Ltd.,Jp Fungicides comprising triazole derivatives as active ingredient and process for producing the active ingredient
US4935564A (en) * 1988-07-28 1990-06-19 Dow Corning Corporation Process for preparing alkyl halides
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M.G. BELSHAM ET AL.: "19F Nuclear Magnetic Resonance Studies of Aromatic Compounds. Part V. Conformational Preferences of Side Chains in ortho-Substituted para-Fluoro-acetophenones, -alpha-methylstyrenes, and -alpha,alpha-dimethyl-benzyl Alcohols", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 2, 1974, LETCHWORTH GB, pages 119 - 125 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835860B2 (en) 2002-02-01 2004-12-28 Merck & Co., Inc. Iodohydroxylation of olefins
WO2011144656A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Preparation of posaconazole intermediates
US9040539B2 (en) 2010-05-19 2015-05-26 Sandoz Ag Process for the preparation of chiral triazolones
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
US9199919B2 (en) 2010-05-19 2015-12-01 Sandoz Ag Process for the preparation of chiral hydrazides
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
US9493428B2 (en) 2011-06-16 2016-11-15 Sandoz Ag Process for the preparation of a chiral compound
CN105777539A (en) * 2016-03-30 2016-07-20 浙江大学宁波理工学院 Synthesis method of 2-[2-(2,4-diflurophenyl)propenyl]-1,3-diethyl malonate
CN105777486A (en) * 2016-03-30 2016-07-20 浙江大学宁波理工学院 Synthesis method of 2-[2-(2,4-diflurophenyl)-2-propen-1-yl)-1,3-propanediol
CN105777486B (en) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 A kind of synthetic method of 2- [2- (2,4- difluorophenyl) -2- propylene -1- bases] -1,3-PD

Also Published As

Publication number Publication date
ATE173456T1 (en) 1998-12-15
EP0734369A1 (en) 1996-10-02
DE69414724T2 (en) 1999-05-27
US5349099A (en) 1994-09-20
EP0734369B1 (en) 1998-11-18
DE69414724D1 (en) 1998-12-24
ES2123949T3 (en) 1999-01-16
CA2178807A1 (en) 1995-06-22
AU1430495A (en) 1995-07-03
JPH09507215A (en) 1997-07-22
SG45428A1 (en) 1998-01-16

Similar Documents

Publication Publication Date Title
EP0734369B1 (en) Process for preparing intermediates for the synthesis of antifungal agents
US5202447A (en) Process of producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
US4331820A (en) Cis-6-undecene-1-chloride and a method for the preparation thereof
JPH069480A (en) Production of 1-fluorocyclopropyl methyl ketone
WO2002018455A1 (en) Resins having vinyl ether linker for the solid phase organic synthesis
JP4609610B2 (en) Process for producing 4-methylpyrazole-5-carboxylic acid compound
US5760267A (en) Process for preparing 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US3952010A (en) Catalytic dehydrogenation process for the preparation of 3,5-disubstituted pyrazoles
Hansen et al. Halogenation of vinyl ketoximes. Synthesis of isoxazoles and preparation and silver ion‐promoted reactions of 4‐halo‐2‐isoxazolines
EP0066943B1 (en) 1,1-diphenylalkenes and a process for their preparation
US4228107A (en) Polyhalogenated hydrocarbons, useful as insecticide intermediates, and methods for their preparation
EP0087596B1 (en) Process for the preparation of 5-substituted 1-chloro-3,3-dimethyl-pentan-2-ones
EP0138849B1 (en) Process for the preparation of lineatin
CA1042019A (en) Processes for the preparation of cyclic aldehydes
JP4329304B2 (en) 1,4-Dibromobutane and process for producing the same
EP0065354B1 (en) Process for the preparation of 1,1-bis phenyl-2-haloalkan-1-ols
JPS6289660A (en) Production of 4-oxo-4,5,6,7-tetrahydroindole
EP0065814A1 (en) 1,1-Bis phenylalkan-1-ols and processes for their preparation
JPS634822B2 (en)
JPH0243733B2 (en) SHINKINANITOROKAGOBUTSUOYOBISONOSEIZOHOHO
JPS6110560A (en) Preparation of 2-tertiary-butyl-4,5-dichloro-3(2h)-pyridazinone
KR19990028250A (en) Method for preparing 1- (3-trialkylsilylphenyl) -2,2,2-trifluoromethyl ethanone derivative
JP2001158757A (en) Method of manufacturing polyprenol
JPS6152811B2 (en)
JPS6366185A (en) Production of tilivalline

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU JP KG KR KZ LK LR LT LV MD MG MN NO NZ PL RO RU SI SK TJ TT UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2178807

Country of ref document: CA

Ref document number: 1995905849

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995905849

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1995905849

Country of ref document: EP